 |
市場調査レポート
日本のジェネリック医薬品市場：産業動向・競合状況・機会・展望Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 |
||||||
| 発行 | IMARC Services Private Limited | 商品コード | 359385 | ||||
| 出版日 | ページ情報 | 英文 98 Pages 納期: 2-3営業日 |
|||||
| 価格 |
|
||||||
| 日本のジェネリック医薬品市場：産業動向・競合状況・機会・展望 Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 | ||
| 出版日: 2019年04月08日 | ページ情報: 英文 98 Pages |
|
日本は金額ベースで世界第8位のジェネリック医薬品市場となっています。しかし、これまでの日本におけるジェネリック医薬品の普及率は、米国や欧州といった他の先進市場と比較して比較的低くなっています。政府は2017年までにジェネリック医薬品の普及率が60%を達成するという目標を定めています。これは国内および外国のジェネリック医薬品メーカーにとって、巨大な機会を生み出すと見込まれています。
当レポートでは、日本のジェネリック医薬品市場における過去・現在・将来の市場動向を詳細に分析し、市場の促進因子、売上動向、処方動向、市場構造、競合状況、規制、主要企業、主要医薬品、製造および展望など、体系的な情報を提供しています。
Japan represents the world's eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe. Historically, the lower penetration of generic drugs in japan was due to several reasons. These included - the perception of inferior quality of generic drugs, the preference of branded drugs among physicians and patients and the limited profits to be made by physicians from pharmaceutical price differentials by prescribing low priced generics. Generic drugs also remained less popular in Japan because of the lack of generic substitution rights by Japanese pharmacists, slower review times in the drug approval process and difficulties working with major pharmaceutical distributors - many of whom were closely tied to major branded drug manufacturers.
The landscape of the japan generic drug market, however, has changed noticeably over the last decade. The Japanese government has identified growth of the country's generic drug market as imperative to Japan's long-term economic health. The Japanese government, recognizing the country's increasing aging population as well as rising costs of branded drugs has begun instituting healthcare policy changes to cut their expenditures on medical costs. Drug costs account for around a fifth of the country's total medical expenses and reducing this burden has become a cornerstone of Japan's health administration policy. Substitution of low-cost generic drugs for innovator products has been identified as a strategy where major savings are possible. Driven by these initiatives, the penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.
The report entitled "Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" represents an in-depth analysis on the historical, current and future market trends in the generic drug market in Japan. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, XXXXXCompetitive LandscapeYYYYY, regulations, key players, key drugs, manufacturing and the outlook of generic drug market in Japan. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the generic drug market in Japan.
